Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552642 · ClinicalTrials.gov registry record · Phase 3
An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children
A Phase 3 study of Obesity and Overweight, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 3
- Development phase
- 77
- Enrollment target
- 3
- Study locations
NCT01552642 is a Phase 3 study of Obesity and Overweight that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 77 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT01552642, a Phase 3 study of Obesity and Overweight, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 77 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall purpose of this study is to develop and implement an effective intervention program designed to prevent and treat obesity in young children.
Conditions Studied
Interventions
- BEHAVIORAL face-to-face meetings and access to a website
Study Locations (3)
Wisconsin
- UW East Towne Clinic - Madison
- UW Pediatrics at 20 S. Park St - Madison
- UW Health West Towne Pediatrics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01552642
The ClinicalTrials.gov registry entry for NCT01552642 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which face-to-face meetings and access to a website is the first listed.
NCT01552642 reports 3 study locations spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01552642 about?
NCT01552642 is a clinical study titled "An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children". The overall purpose of this study is to develop and implement an effective intervention program designed to prevent and treat obesity in young children.
What is the current status of trial NCT01552642?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 77 participants. The study started on 2013-02. Estimated completion is 2015-05.
What conditions does trial NCT01552642 study?
This clinical trial studies the following conditions: Obesity, Overweight, Child.
What interventions are being tested in trial NCT01552642?
The interventions under investigation include: face-to-face meetings and access to a website (BEHAVIORAL).
Who is sponsoring clinical trial NCT01552642?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01552642 being conducted?
This trial has 3 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.